Mon, December 21, 2020
Sun, December 20, 2020
Fri, December 18, 2020
Thu, December 17, 2020

Tazeen Ahmad Maintained (SRPT) at Strong Buy and Held Target at $194 on, Dec 18th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-194-on-dec-18th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Tazeen Ahmad of B of A Securities, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $194 on, Dec 18th, 2020.

Tazeen has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 1 agrees with Tazeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Martin Auster of "Credit Suisse" Maintained at Hold with Decreased Target to $156 on, Monday, December 14th, 2020


These are the ratings of the 5 analyists that currently disagree with Tazeen


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $197 on, Friday, November 6th, 2020
  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $221 on, Monday, August 31st, 2020
  • Danielle Brill of "Raymond James" Initiated at Buy and Held Target at $200 on, Tuesday, August 25th, 2020